{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:40:19Z","timestamp":1790484019281,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the grant from the Key Laboratory of Microcosmic Syndrome Differentiation"},{"name":"Yunnan Province Natural Science Foundation of China","award":["30172110104"],"award-info":[{"award-number":["30172110104"]}]},{"DOI":"10.13039\/501100005147","name":"Applied Basic Research Key Project of Yunnan","doi-asserted-by":"crossref","award":["2019FF002 (-055)"],"award-info":[{"award-number":["2019FF002 (-055)"]}],"id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes complications are the leading cause of mortality in diabetic patients. The common complications are decline in antioxidant capacity and the onset of micro-inflammation syndrome. At present, glucose-responsive nanoparticles are widely used, as they can release insulin-loaded ultrafine particles intelligently and effectively reduce blood sugar. However, the toxicology of this method has not been fully elucidated. The plant extracts of pterostilbene (PTE) have a wide range of biological applications, such as antioxidation and inflammatory response improvement. Therefore, we have proposed new ideas for the cross application of plant extracts and biomaterials, especially as part of a hypoglycaemic nano-drug delivery system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on the PTE, we successfully synthesised poly(3-acrylamidophenyl boric acid-b-pterostilbene) (p[AAPBA-b-PTE]) nanoparticles (NPs). The NPs were round in shape and ranged between 150 and 250\u00a0nm in size. The NPs possessed good pH and glucose sensitivity. The entrapment efficiency (EE) of insulin-loaded NPs was approximately 56%, and the drug loading (LC) capacity was approximately 13%. The highest release of insulin was 70%, and the highest release of PTE was 85%. Meanwhile, the insulin could undergo self-regulation according to changes in the glucose concentration, thus achieving an effective, sustained release. Both in vivo and in vitro experiments showed that the NPs were safe and nontoxic. Under normal physiological conditions, NPs were completely degraded within 40\u00a0days. Fourteen days after mice were injected with p(AAPBA-b-PTE) NPs, there were no obvious abnormalities in the heart, liver, spleen, lung, or kidney. Moreover, NPs effectively reduced blood glucose, improved antioxidant capacity and reversed micro-inflammation in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>p(AAPBA-b-PTE) NPs were successfully prepared using PTE as raw material and effectively reduced blood glucose, improved antioxidant capacity and reduced the inflammatory response. This novel preparation can enable new combinations of plant extracts and biomaterials to adiministered through NPs or other dosage forms in order to regulate and treat diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-021-00928-y","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T14:20:47Z","timestamp":1624803647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications"],"prefix":"10.1186","volume":"19","author":[{"given":"Xi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-5299","authenticated-orcid":false,"given":"Junzi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"issue":"10085","key":"928_CR1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(17)31537-4","volume":"389","author":"T Lancet","year":"2017","unstructured":"Lancet T. Diabetes: a dynamic disease. Lancet. 2017;389(10085):2163.","journal-title":"Lancet"},{"issue":"1","key":"928_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137\u201388.","journal-title":"Physiol Rev"},{"issue":"Suppl 2","key":"928_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/dmrr.512","volume":"20","author":"C Valeri","year":"2004","unstructured":"Valeri C, Pozzilli P, Leslie D. Glucose control in diabetes. Diabetes Metab Res Rev. 2004;20(Suppl 2):S1-8.","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"928_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10654-019-00548-9","volume":"34","author":"N van der Schaft","year":"2019","unstructured":"van der Schaft N, Schoufour JD, Nano J, Kiefte-de Jong JC, Muka T, Sijbrands EJG, Ikram MA, Franco OH, Voortman T. Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study. Eur J Epidemiol. 2019;34(9):853\u201361.","journal-title":"Eur J Epidemiol"},{"issue":"39","key":"928_CR5","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab9e26","volume":"31","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Song B, He D, Xia Z, Wang P, Wu J, Li Y. Galactose-based polymer-containing phenylboronic acid as carriers for insulin delivery. Nanotechnology. 2020;31(39):395601","journal-title":"Nanotechnology."},{"key":"928_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/IJN.S284357","volume":"16","author":"Q Ma","year":"2021","unstructured":"Ma Q, Zhao X, Shi A, Wu J. Bioresponsive functional phenylboronic acid-based delivery system as an emerging platform for diabetic therapy. Int J Nanomedicine. 2021;16:297\u2013314.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"928_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/jacs.6b10773","volume":"139","author":"RW Gunasekara","year":"2017","unstructured":"Gunasekara RW, Zhao Y. A general method for selective recognition of monosaccharides and oligosaccharides in water. J Am Chem Soc. 2017;139(2):829\u201335.","journal-title":"J Am Chem Soc"},{"issue":"49","key":"928_CR8","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1039\/C6CC02202B","volume":"52","author":"L Zhao","year":"2016","unstructured":"Zhao L, Xiao C, Wang L, Gai G, Ding J. Glucose-sensitive polymer NPs for self-regulated drug delivery. Chem Commun (Camb). 2016;52(49):7633\u201352.","journal-title":"Chem Commun (Camb)"},{"issue":"37","key":"928_CR9","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.2174\/0929867325666181008144436","volume":"26","author":"JH Ryu","year":"2019","unstructured":"Ryu JH, Lee GJ, Shih YV, Kim TI, Varghese S. Phenylboronic acid-polymers for biomedical applications. Curr Med Chem. 2019;26(37):6797\u2013816.","journal-title":"Curr Med Chem"},{"issue":"5","key":"928_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1021\/bm034139o","volume":"4","author":"A Matsumoto","year":"2003","unstructured":"Matsumoto A, Ikeda S, Harada A, Kataoka K. Glucose-responsive polymer bearing a novel phenylborate derivative as a glucose-sensing moiety operating at physiological pH conditions. Biomacromol. 2003;4(5):1410\u20136.","journal-title":"Biomacromol"},{"issue":"4","key":"928_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejps.2013.04.027","volume":"49","author":"C Zheng","year":"2013","unstructured":"Zheng C, Guo Q, Wu Z, Sun L, Zhang Z, Li C, Zhang X. Amphiphilic glycopolymer NPs as vehicles for nasal delivery of peptides and proteins. Eur J Pharm Sci. 2013;49(4):474\u201382.","journal-title":"Eur J Pharm Sci"},{"key":"928_CR12","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.2147\/IJN.S220936","volume":"14","author":"JZ Wu","year":"2019","unstructured":"Wu JZ, Yang Y, Li S, Shi A, Song B, Niu S, Chen W, Yao Z. Glucose-sensitive nanoparticles based on poly(3-acrylamidophenylboronic acid-block-n-vinylcaprolactam) for insulin delivery. Int J Nanomedicine. 2019;14:8059\u201372.","journal-title":"Int J Nanomedicine"},{"key":"928_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.msec.2017.03.139","volume":"76","author":"JZ Wu","year":"2017","unstructured":"Wu JZ, Bremner DH, Li HY, Niu SW, Li SD, Zhu LM. Phenylboronic acid-diol crosslinked 6-O-vinylazeloyl-d-galactose nanocarriers for insulin delivery. Mater Sci Eng C Mater Biol Appl. 2017;76:845\u201355.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"928_CR14","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.2147\/IJN.S132984","volume":"12","author":"JZ Wu","year":"2017","unstructured":"Wu JZ, Williams GR, Li HY, Wang D, Wu H, Li SD, Zhu LM. Glucose- and temperature-sensitive nanoparticles for insulin delivery. Int J Nanomedicine. 2017;12:4037\u201357.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"928_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addr.2011.09.001","volume":"64","author":"A Elsaesser","year":"2012","unstructured":"Elsaesser A, Howard CV. Toxicology of NPs. Adv Drug Deliv Rev. 2012;64(2):129\u201337.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"928_CR16","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3390\/ijms17111927","volume":"17","author":"B Xie","year":"2016","unstructured":"Xie B, Xu Z, Hu L, Chen G, Wei R, Yang G, Li B, Chang G, Sun X, Wu H, Zhang Y, Dai B, Tao Y, Shi J, Zhu W. PTE inhibits human multiple myeloma cells via ERK1\/2 and JNK pathway in vitro and in vivo. Int J Mol Sci. 2016;17(11):1927.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"928_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jfda.2016.07.004","volume":"25","author":"HY Tsai","year":"2017","unstructured":"Tsai HY, Ho CT, Chen YK. Biological actions and molecular effects of resveratrol, PTE, and 3\u2019-hydroxyPTE. J Food Drug Anal. 2017;25(1):134\u201347.","journal-title":"J Food Drug Anal"},{"key":"928_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2016.07.046","volume":"789","author":"R Kosuru","year":"2016","unstructured":"Kosuru R, Rai U, Prakash S, Singh A, Singh S. Promising therapeutic potential of PTE and its mechanistic insight based on preclinical evidence. Eur J Pharmacol. 2016;789:229\u201343.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"928_CR19","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.jss.2011.09.054","volume":"173","author":"D McCormack","year":"2012","unstructured":"McCormack D, McFadden D. PTE and cancer: current review. J Surg Res. 2012;173(2):e53-61.","journal-title":"J Surg Res"},{"key":"928_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jnutbio.2017.02.009","volume":"43","author":"K Nagao","year":"2017","unstructured":"Nagao K, Jinnouchi T, Kai S, Yanagita T. PTE, a dimethylated analog of resveratrol, promotes energy metabolism in obese rats. J Nutr Biochem. 2017;43:151\u20135.","journal-title":"J Nutr Biochem"},{"key":"928_CR21","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3389\/fimmu.2019.02408","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu H, Wu X, Luo J. PTE attenuates astrocytic inflammation and neuronal oxidative injury after ischemia-reperfusion by inhibiting NF-\u03baB phosphorylation. Front Immunol. 2019;10:2408.","journal-title":"Front Immunol"},{"key":"928_CR22","doi-asserted-by":"publisher","first-page":"9012352","DOI":"10.1155\/2018\/9012352","volume":"2018","author":"B Tastekin","year":"2018","unstructured":"Tastekin B, Pelit A, Polat S, Tuli A, Sencar L, Alparslan MM, Daglioglu YK. Therapeutic potential of PTE and resveratrol on biomechanic, biochemical, and histological parameters in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2018;2018:9012352.","journal-title":"Evid Based Complement Alternat Med"},{"key":"928_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2017.06.015","volume":"182","author":"R Kosuru","year":"2017","unstructured":"Kosuru R, Singh S. PTE ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats. Life Sci. 2017;182:112\u201321.","journal-title":"Life Sci"},{"issue":"2","key":"928_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ptr.2277","volume":"22","author":"CM Remsberg","year":"2008","unstructured":"Remsberg CM, Y\u00e1\u00f1ez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res. 2008;22(2):169\u201379.","journal-title":"Phytother Res"},{"issue":"5","key":"928_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13205-020-02167-8","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Lian W, Wang G, Qiu M, Lin L, Zeng R. Pterostilbene induces Nrf2\/HO-1 and potentially regulates NF-\u03baB and JNK-Akt\/mTOR signaling in ischemic brain injury in neonatal rats. 3 Biotech. 2020;10(5):192.","journal-title":"3 Biotech."},{"issue":"Suppl 2","key":"928_CR26","first-page":"84","volume":"31","author":"T Perecko","year":"2010","unstructured":"Perecko T, Drabikova K, Rackova L, Ciz M, Podborska M, Lojek A, Harmatha J, Smidrkal J, Nosal R, Jancinova V. Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro. Neuro Endocrinol Lett. 2010;31(Suppl 2):84\u201390.","journal-title":"Neuro Endocrinol Lett"},{"issue":"12","key":"928_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/bmc.1254","volume":"23","author":"HS Lin","year":"2009","unstructured":"Lin HS, Yue BD, Ho PC. Determination of PTE in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr. 2009;23(12):1308\u201315.","journal-title":"Biomed Chromatogr"},{"key":"928_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","volume":"244","author":"SN Goyal","year":"2016","unstructured":"Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, Agrawal YO. Challenges and issues with streptozotocin-induced diabetes\u2014a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact. 2016;244:49\u201363.","journal-title":"Chem Biol Interact"},{"key":"928_CR29","doi-asserted-by":"publisher","first-page":"2902351","DOI":"10.1155\/2016\/2902351","volume":"2016","author":"A Heydemann","year":"2016","unstructured":"Heydemann A. An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus. J Diabetes Res. 2016;2016:2902351.","journal-title":"J Diabetes Res"},{"issue":"1","key":"928_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejpb.2012.05.013","volume":"82","author":"X Zhang","year":"2012","unstructured":"Zhang X, Wang Y, Zheng C, Li C. Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory. Eur J Pharm Biopharm. 2012;82(1):76\u201384.","journal-title":"Eur J Pharm Biopharm"},{"issue":"23","key":"928_CR31","doi-asserted-by":"publisher","first-page":"19355","DOI":"10.1021\/acsami.8b01954","volume":"10","author":"S Liu","year":"2018","unstructured":"Liu S, Ono RJ, Yang C, Gao S, Ming Tan JY, Hedrick JL, Yang YY. Dual pH-responsive shell-cleavable polycarbonate micellar nanoparticles for in vivo anticancer drug delivery. ACS Appl Mater Interfaces. 2018;10(23):19355\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"key":"928_CR32","first-page":"186864","volume":"2014","author":"SZ Moghadamtousi","year":"2014","unstructured":"Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864.","journal-title":"Biomed Res Int."},{"key":"928_CR33","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.2147\/IJN.S208332","volume":"14","author":"H Yavarpour-Bali","year":"2019","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M. Curcumin-loaded NPs: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomedicine. 2019;14:4449\u201360.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"928_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules25030689","volume":"25","author":"M Moballegh Nasery","year":"2020","unstructured":"Moballegh Nasery M, Abadi B, Poormoghadam D, Zarrabi A, Keyhanvar P, Khanbabaei H, Ashrafizadeh M, Mohammadinejad R, Tavakol S, Sethi G. Curcumin Delivery Mediated by Bio-Based NPs: A Review. Molecules. 2020;25(3):689.","journal-title":"Molecules"},{"key":"928_CR35","doi-asserted-by":"publisher","first-page":"127893","DOI":"10.1016\/j.foodchem.2020.127893","volume":"340","author":"R Meng","year":"2021","unstructured":"Meng R, Wu Z, Xie QT, Cheng JS, Zhang B. Preparation and characterization of zein\/carboxymethyl dextrin NPs to encapsulate curcumin: physicochemical stability, antioxidant activity and controlled release properties. Food Chem. 2021;340:127893.","journal-title":"Food Chem."},{"issue":"2","key":"928_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ab.2007.09.001","volume":"372","author":"X Li","year":"2008","unstructured":"Li X, Pennington J, Stobaugh JF, Sch\u00f6neich C. Synthesis of sulfonamide- and sulfonyl-phenylboronic acid-modified silica phases for boronate affinity chromatography at physiological pH. Anal Biochem. 2008;372(2):227\u201336.","journal-title":"Anal Biochem"},{"issue":"6","key":"928_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1039\/c3sm52485j","volume":"10","author":"Q Guo","year":"2014","unstructured":"Guo Q, Wu Z, Zhang X, Sun L, Li C. Phenylboronate-diol crosslinked glycopolymeric nanocarriers for insulin delivery at physiological pH. Soft Matter. 2014;10(6):911\u201320.","journal-title":"Soft Matter"},{"key":"928_CR38","doi-asserted-by":"publisher","first-page":"109810","DOI":"10.1016\/j.msec.2019.109810","volume":"104","author":"M Ayubi","year":"2019","unstructured":"Ayubi M, Karimi M, Abdpour S, Rostamizadeh K, Parsa M, Zamani M, Saedi A. Magnetic NPs decorated with PEGylated curcumin as dual targeted drug delivery: Synthesis, toxicity and biocompatibility study. Mater Sci Eng C Mater Biol Appl. 2019;104:109810.","journal-title":"Mater Sci Eng C Mater Biol Appl."},{"issue":"1","key":"928_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1208\/s12248-016-0010-3","volume":"19","author":"M Li","year":"2017","unstructured":"Li M, Zou P, Tyner K, Lee S. Physiologically based pharmacokinetic (PBPK) modeling of pharmaceutical NPs. AAPS J. 2017;19(1):26\u201342.","journal-title":"AAPS J"},{"issue":"14","key":"928_CR40","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1039\/c3nr00835e","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, L\u00fc S, Gao C, Chen C, Zhang X, Liu M. Highly stable and degradable multifunctional microgel for self-regulated insulin delivery under physiological conditions. Nanoscale. 2013;5(14):6498\u2013506.","journal-title":"Nanoscale"},{"key":"928_CR41","doi-asserted-by":"publisher","first-page":"115506","DOI":"10.1016\/j.carbpol.2019.115506","volume":"229","author":"MA Mumuni","year":"2020","unstructured":"Mumuni MA, Kenechukwu FC, Ofokansi KC, Attama AA, D\u00edaz DD. Insulin-loaded mucoadhesive NPs based on mucin-chitosan complexes for oral delivery and diabetes treatment. Carbohydr Polym. 2020;229:115506.","journal-title":"Carbohydr Polym."},{"issue":"48","key":"928_CR42","doi-asserted-by":"publisher","first-page":"45276","DOI":"10.1021\/acsami.9b16047","volume":"11","author":"T Chen","year":"2019","unstructured":"Chen T, Liu W, Xiong S, Li D, Fang S, Wu Z, Wang Q, Chen X. NPs mediating the sustained puerarin release facilitate improved brain delivery to treat Parkinson\u2019s disease. ACS Appl Mater Interfaces. 2019;11(48):45276\u201389.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"928_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/biof.1410","volume":"44","author":"P Wang","year":"2018","unstructured":"Wang P, Sang S. Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors. 2018;44(1):16\u201325.","journal-title":"BioFactors"},{"key":"928_CR44","first-page":"5501","volume":"7","author":"V Sanna","year":"2012","unstructured":"Sanna V, Roggio AM, Siliani S, Piccinini M, Marceddu S, Mariani A, Sechi M. Development of novel cationic chitosan-and anionic alginate-coated poly(D, L-lactide-co-glycolide) NPs for controlled release and light protection of resveratrol. Int J Nanomed. 2012;7:5501\u201316.","journal-title":"Int J Nanomed"},{"issue":"16","key":"928_CR45","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A, Souto EB. Polymeric NPs: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25(16):3731.","journal-title":"Molecules"},{"issue":"33","key":"928_CR46","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jafc.9b03208","volume":"67","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhang J, Gao G, Wang H, He X, Chen T, Ke L, Rao P, Wang Q. Boiling licorice produces self-assembled protein NPs: a novel source of bioactive nanomaterials. J Agric Food Chem. 2019;67(33):9354\u201361.","journal-title":"J Agric Food Chem"},{"key":"928_CR47","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.2147\/IJN.S185259","volume":"13","author":"L Feng","year":"2018","unstructured":"Feng L, Yang X, Shi Y, Liang S, Zhao T, Duan J, Sun Z. Co-exposure subacute toxicity of silica NPs and lead acetate on cardiovascular system. Int J Nanomed. 2018;13:7819\u201334.","journal-title":"Int J Nanomed"},{"key":"928_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-030-12668-1_7","volume":"1134","author":"T Suksangrat","year":"2019","unstructured":"Suksangrat T, Phannasil P, Jitrapakdee S. miRNA regulation of glucose and lipid metabolism in relation to diabetes and non-alcoholic fatty liver disease. Adv Exp Med Biol. 2019;1134:129\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"928_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","volume":"144","author":"R Mohammadpour","year":"2019","unstructured":"Mohammadpour R, Dobrovolskaia MA, Cheney DL, Greish KF, Ghandehari H. Subchronic and chronic toxicity evaluation of inorganic NPs for delivery applications. Adv Drug Deliv Rev. 2019;144:112\u201332.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"928_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and NPs:applications and hazards. Int J Nanomedicine. 2008;3(2):133\u201349.","journal-title":"Int J Nanomedicine"},{"key":"928_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijbiomac.2018.08.152","volume":"120","author":"Q Hu","year":"2018","unstructured":"Hu Q, Luo Y. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery. Int J Biol Macromol. 2018;120:775\u201382.","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"928_CR52","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3390\/molecules24183257","volume":"24","author":"T Taili Shao","year":"2019","unstructured":"Taili Shao T, Yuan P, Zhu L, Xu H, Li X, He S, Li P, Wang G, Chen K. Carbon NPs inhibit \u0391-glucosidase activity and induce a hypoglycemic effect in diabetic mice. Molecules. 2019;24(18):3257.","journal-title":"Molecules"},{"issue":"2","key":"928_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5582\/bst.2019.01020","volume":"13","author":"P Goycheva","year":"2019","unstructured":"Goycheva P, Nikolova G, Ivanova M, Kundurdzhiev T, Gadjeva V. Predictive value of some pro-oxidants in type 2 diabetes mellitus with vascular complications. Biosci Trends. 2019;13(2):168\u201375.","journal-title":"Biosci Trends"},{"issue":"8","key":"928_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1902\/jop.2008.080246","volume":"79","author":"GL King","year":"2008","unstructured":"King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8):1527\u201334.","journal-title":"J Periodontol"},{"issue":"5","key":"928_CR55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","volume":"62","author":"O Yousuf","year":"2013","unstructured":"Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397\u2013408.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00928-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-021-00928-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00928-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T14:20:54Z","timestamp":1624803654000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-00928-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-00928-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,27]]},"assertion":[{"value":"16 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were undertaken following a robust ethical review and in accordance with the procedures authorised by the Committee for Experimental Animal Welfare and Ethics of Yunnan University of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}